HAEMATO
Haemato is a pharmaceutical company that develops customized medical devices for healthcare sectors.
HAEMATO
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
1993-01-01
Address:
Schönefeld, Brandenburg, Germany
Country:
Germany
Website Url:
http://www.haemato.ag
Total Employee:
251+
Status:
Active
Contact:
49-30 897 30 86 70
Email Addresses:
[email protected]
Technology used in webpage:
Apple Mobile Web Clips Icon Organization Schema IPv6 COVID-19 ContactPoint Schema Autoptimize WordPress 5.7 1and1 Usercentrics Hornetsecurity
Similar Organizations
Fertigo Medical
Fertigo Medical is a medical company that develops medical devices for IVF.
Ursapharm Arzneimittel
Ursapharm Arzneimittel is a pharmaceutical company that offers medicinal products and medical devices for ophthalmology & generic medicine.
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-15 | M1 Aesthetics | M1 Aesthetics acquired by Haemato | N/A |
Official Site Inspections
http://www.haemato.ag
- Host name: 217-160-0-19.elastic-ssl.ui-r.com
- IP address: 217.160.0.19
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Haemato"
Company - HAEMATO
HAEMATO — Well Established. ... 2023: The Management Board of HAEMATO AG ("Company"; ISIN: DE000A289VV1/ Open Market / Basic Board) has decided today, November 30, 2023, …See details»
HAEMATO AG (HAM: HAEK) Company Profile & Overview - Stock …
6 days ago HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The …See details»
Haemato - Crunchbase Company Profile & Funding
Also Known As Haemato Ag O.N. Stock Symbol ETR:HAE ; Company Type For Profit; Contact Email [email protected]; Phone Number 49-30 897 30 86 70; …See details»
Haemato Company Profile: Stock Performance
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in …See details»
Your Partner for Specialty Pharma - HAEMATO
HAEMATO Your Partner for Specialty Pharma. For more than 15 years, HAEMATO has been committed to help reduce costs in the healthcare sector so that every patient can benefit from the latest therapies and treatment options, …See details»
HAEMATO AG: Governance, Directors and Executives
May 29, 2013 Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic …See details»
HAEMATO AG Company Profile | Schönefeld ... - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HAEMATO AG of Schönefeld, Brandenburg. Get the latest business insights from Dun & Bradstreet.See details»
Haemato AG, HAAGF:PNK profile - FT.com - Financial Times
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus …See details»
Haemato AG (HAEK) | Investor Relations Data & Reports
Browse Haemato AG's (HAEK) investor relations materials including 2024 annual reports, financial statements, ESG data, and company filings.See details»
Haemato AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Haemato AG with its drug pipeline, therapeutic area, technology platform, 2 news. Explore Haemato AG with its drug pipeline, therapeutic area, technology platform, 2 news. …See details»
HAEMATO AG (HAM: HAEK) Stock Price & Overview - Stock Analysis
Dec 30, 2024 HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. …See details»
2018 - HAEMATO
HAEMATO AG shares, 887,154 no-par-value bearer shares were issued as part of a conditional capital increase. Being one of the leading eight players in the parallel import business in the …See details»
HAEMATO AG Company Profile & Data: stocks, market cap, …
Jan 1, 2024 HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and …See details»
HAEMATO AG (HAEK.HM) - Yahoo Finance
HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany. www.haemato.ag . 76. Full Time Employees. December 31. Fiscal Year Ends. Healthcare . Sector. Drug …See details»
HAEMATO AG (von GBC AG): Management Interview
In operational terms, HAEMATO AG is heading for a record year following the acquisition of M1 Aesthetics GmbH. In addition, the expansion of their private label business is increasingly …See details»
HAEMATO AG Revenue - Stock Analysis
Dec 30, 2024 HAEMATO AG had revenue of 133.64M EUR in the half year ending June 30, 2023, a decrease of -11.80%. This brings the company's revenue in the last twelve months to …See details»
HAAGF - Stock Quotes for Haemato AG - Webull
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus …See details»
Notification concerning ordinary capital reduction - HAEMATO
Sep 1, 2020 HAEMATO AG shall not provide for refunds of charges. The price determination for the 2,286,715 converted shares resulting from the capital reduction with the new ISIN …See details»
Calculating The Fair Value Of HAEMATO AG (HMSE:HAEK) - Yahoo …
Nov 26, 2024 Using the 2 Stage Free Cash Flow to Equity, HAEMATO fair value estimate is €10.82 With €12.80 share price, HAEMATO appears to be trading close to its estimated fair valueSee details»
Pharmaceuticals - HAEMATO
HAEMATO covers chronic diseases as well as high-priced therapies in particular via a specialised portfolio. The focus is on the five major therapeutic areas of HIV/AIDS, neurology, oncology, …See details»